UK approves Pfizer-BioNTech vaccine for rollout from next week
Britain on Wednesday became the first Western country to approve a Covid-19 vaccine for general use as it announced a rollout of Pfizer-BioNTech’s vaccine from next week. “The government has…
AstraZeneca, Oxford University say COVID-19 vaccine shows 70% efficacy
British drugs group AstraZeneca and the University of Oxford on Monday said their jointly-developed vaccine against COVID-19 has shown “an average efficacy of 70 percent” in trials. “This vaccine’s efficacy…
Meet the Nigerian doctor behind the Pfizer Covid-19 vaccine breakthrough
Dr. Onyema E. Ogbuagu, a Nigerian-American is one of the medical masterminds behind the Pfizer Covid-19 vaccine breakthrough. Dr. Ogbuagu is a twin son of Professor Chibuzor Ogbuagu, a former…
EU could pay over $10 billion for Pfizer, CureVac vaccines – source
The European Union could pay more than $10 billion to secure hundreds of millions of doses of the vaccine candidates being developed by Pfizer-BioNTech and CureVac, an EU official involved…
COVID-19: Pfizer-BioNTech vaccine deliveries could begin Dec.
Pfizer Inc and BioNTech could secure emergency U.S. and European authorization for their COVID-19 vaccine next month after final trial results showed it had a 95% success rate and no…
Pfizer to begin pilot delivery program for its COVID-19 vaccine in four U.S. states
Pfizer Inc has launched a pilot delivery program for its experimental COVID-19 vaccine in four U.S. states, as the U.S. drugmaker seeks to address distribution challenges facing its ultra-cold storage…
Moderna says its experimental vaccine is 94.5% effective in preventing COVID-19
Moderna Inc said on Monday its experimental vaccine was 94.5% effective in preventing COVID-19 based on interim data from a late-stage clinical trial, becoming the second U.S. company in a…
COVID-19: WHO says vaccine safety top priority, as AstraZeneca pauses study
Safety of a prospective vaccine for COVID-19 comes “first and foremost”, the World Health Organization’s chief scientist said on Wednesday, as a trial of a candidate from AstraZeneca was paused,…
US acquires 100m doses of potential coronavirus vaccine for $1.95bn
The US government has agreed to pay $1.95 billion (1.68 billion euros) to secure 100 million doses of a potential coronavirus vaccine being developed by US pharma giant Pfizer and…
COVID-19: Wave of promising study results raises hope for vaccines
Early data from trials of three potential COVID-19 vaccines released on Monday, including a closely-watched candidate from Oxford University, increased confidence that a vaccine can train the immune system to…